Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Income from Continuing Operations (2016 - 2025)

Wave Life Sciences' Income from Continuing Operations history spans 11 years, with the latest figure at 53179000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 281.79% year-over-year to 53179000.0; the TTM value through Dec 2025 reached 204378000.0, down 110.68%, while the annual FY2025 figure was 204378000.0, 110.68% down from the prior year.
  • Income from Continuing Operations reached 53179000.0 in Q4 2025 per WVE's latest filing, up from 53852000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 29253000.0 in Q4 2024 to a low of 61780000.0 in Q3 2024.
  • Average Income from Continuing Operations over 5 years is 32147200.0, with a median of 38290000.0 recorded in 2021.
  • The largest YoY upside for Income from Continuing Operations was 279.95% in 2024 against a maximum downside of 949.21% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 34785000.0 in 2021, then decreased by 25.65% to 43709000.0 in 2022, then surged by 62.81% to 16256000.0 in 2023, then soared by 279.95% to 29253000.0 in 2024, then plummeted by 281.79% to 53179000.0 in 2025.
  • Per Business Quant, the three most recent readings for WVE's Income from Continuing Operations are 53179000.0 (Q4 2025), 53852000.0 (Q3 2025), and 50469000.0 (Q2 2025).